Where healthcare AI has proof, and where it does not

Seven categories scored on published evidence and market momentum. Three quoted numbers traced to what they measure. Six use cases scored on three outcomes at once. Every figure links to where it came from.

By Tyler KentUpdated

Part one

The map

The map asks how strong the evidence is and, separately, which way the market is moving. With evidence on one axis and momentum on the other, the categories fall into four groups.

Fig. 1

Evidence against momentum

  • Adopt
  • Pilot
  • Watch
  • Hold
  • Bubble size: deployment readiness

Step 1 of 8

Seven places hospitals spend on AI

Documentation, administrative work, care transitions, diagnostics, the workforce, chronic disease and behavioral health.

Step 2 of 8

Sort them by how good the proof is

Left to right: early concept, single-site results, consistent pilots, peer-reviewed multi-site data. Only published results move a category along this line.

Step 3 of 8

Then by market momentum

Bottom to top: contested, steady, building, accelerating. Momentum combines investment, adoption and regulation, and a category's momentum and evidence often differ: some move fast on thin proof, and some well-proven ones move slowly.

Step 4 of 8

Proven and moving

Documentation and diagnostics have strong evidence and strong momentum. Documentation is the easier of the two to buy, though one vendor quotes bigger time savings than the first major study across several vendors found. For diagnostics, a 2026 study in routine practice found two radiologists more sensitive than two commercial AI systems at finding lung nodules.

Step 5 of 8

Momentum ahead of evidence

Chronic disease management and workforce tools are growing faster than the evidence behind them. Workforce relief cannot yet be bought as a single product, and chronic disease monitoring needs staff assigned to act on the readings. A narrow, measured pilot is the sensible step.

Step 6 of 8

Strong evidence, slow market

Care transitions has the strongest combined cost and outcome evidence on the map, and it is the only category here with a published result in which a racial gap in readmissions closed. Adoption is still slow. The programs that work pair an AI model that flags high-risk patients with staff who follow up with those patients, and those staff are the hard part to fund.

For hospitals in CMS's mandatory TEAM model, care transitions now affect payment directly, because TEAM counts spending through 30 days after discharge against each surgery's target. We publish a free position report for any participating hospital.

Step 7 of 8

How hard each one is to deploy

Bubble size is deployment readiness this year. Documentation is the easiest to deploy. Behavioral health is small for a reason: two states ban AI therapy chatbots outright, and in the first three months of 2026, 36 states introduced more than 70 bills to regulate AI chatbots.

Step 8 of 8

The verdicts

Two categories are rated Adopt, three Pilot, one Watch and one Hold. Select a bubble in the explorer below for the sources behind each rating.

Tyler Kent scored each category in September 2026, from published literature and public regulatory activity. The explorer lists the sources behind every score.

Show Fig. 1 as a table
Seven healthcare AI categories, each scored 1 to 4 on three measures, with the verdict.
CategoryEvidenceMomentumDeployment readinessVerdict
Clinical documentationStrongAcceleratingReadyAdopt
Administrative wasteModerateContestedWorkablePilot
Care coordination and transitionsStrongSteadyWorkableAdopt
Diagnostic capacityStrongAcceleratingWorkablePilot
Workforce and burnoutModerateAcceleratingHeavy liftWatch
Chronic disease managementEmergingAcceleratingWorkablePilot
Behavioral health accessEarlyContestedHardHold

83%

One limit that applies to every tool built on a language model

Large language models reproduce errors that are already present in the input. Across six leading models and 300 physician-validated vignettes, each seeded with one fabricated lab value, sign or condition, the models repeated the planted error in up to 83% of cases. A prompt written to prevent the errors cut the average across the six models from 66% to 44%, which is still too high to be safe. This applies to any tool built on a language model, and it limits how much those tools should run without human review.

Source: Communications Medicine, 2025

Part two

Three numbers you have seen in a deck

Each has been quoted in public, and the link shows where. Next to it is what the original source measured.

Fig. 2 · What circulates

320%

“Clinical documentation AI use will grow 320% by 2026.”

Seen in Healthcare Dive, sponsored content, 2025

The source says something else

Executives using an AI documentation tool10%
Executives planning to use one by 202642%

The 320% comes from setting the 42% who planned to use a tool against the 10% who used one, so it compares a plan with current use.

The figure measures intent rather than use. In a Microsoft-sponsored survey of 130 healthcare executives, 42% said they planned to implement an AI documentation tool by 2026 against 10% using one, and 42 over 10 was reported as 320% growth. A published market forecast for the segment puts growth at about 21% a year from 2026 to 2031.

Market forecast: ResearchAndMarkets, AI in Clinical Documentation Market, 2026

Fig. 3 · What circulates

$44B

“Unplanned hospital readmissions waste up to $44 billion a year.”

Seen in a journal article citing all-payer waste estimates, 2016

The figure is broader than it sounds

As quoted: all payers, top of an "up to" range$44B
Medicare, all readmissions$15–26B
Medicare, avoidable readmissionsup to $17B

Figures are in billions of dollars a year. The quoted $44 billion is the top of a range for all payers, and the other two bars are Medicare only.

The $44 billion is the top of an "up to" range for unplanned readmissions across all payers, quoted inside a $355 billion estimate of US healthcare waste from failed care delivery, poor care coordination and overtreatment. The Medicare-specific figures are $15 to 26 billion a year for all readmissions, of which officials estimate up to $17 billion is avoidable. So the $44 billion counts unplanned readmissions for all payers, and an unplanned readmission is not always an avoidable one.

Primary source: Harvard Kennedy School, Transitional Care Models for the Elderly

Fig. 4 · What circulates

60% · 35%

“HIMSS Analytics found automated prior authorization cuts processing time 60% and administrative cost 35%.”

Seen in a vendor comparison page, 2026

No source found

60%less processing time
35%lower administrative cost

Source: none located

Attributed to HIMSS Analytics. No HIMSS publication stating either figure could be located.

The sentence appears on a prior-authorization vendor's comparison page, attributed to HIMSS Analytics. That page links the figures to a general HIMSS web page about AI, not to a report, and no HIMSS publication stating either figure could be located. Separately, a 2026 report from the Peterson Health Technology Institute found that AI may cut what each organization spends on prior authorization but has not lowered costs across the system.

Primary source: Peterson Health Technology Institute, Administrative AI: Current Use and Potential Impact, 2026

Part three

Six use cases, three outcomes

A healthcare AI business case can rest on one outcome and assume the other two. This scores six use cases on clinical, operational and financial outcomes, with the evidence attached.

Fig. 5

Each use case scored on three outcomes

Use caseClinicalPatient outcomes and experienceOperationalThroughput and workforce reliefFinancialMargin and revenue protectionAll three?
Discharge and transition optimizationCare coordinationStrongStrongStrongYes
Dementia care coordinationChronic and cognitive careModerateModerateStrongYes
Ambient clinical documentationDocumentation burdenEmergingModerateEmergingNo
Remote monitoring for high-risk patientsChronic disease managementEmergingModerateModerateNo
Prior authorization automationAdministrative wasteEmergingModerateEmergingNo
Emergency risk stratification for older adultsFront-door capacityEmergingModerateEmergingNo

Strong Moderate Emerging WeakA use case meets the bar when all three reach Moderate or better

Step 1 of 6

Six use cases

Discharge and transitions, dementia care coordination, ambient documentation, remote monitoring, prior authorization and emergency risk stratification. Each is scored on three outcomes that have to hold at the same time.

Step 2 of 6

Score the patient outcomes

This column asks whether patients are better off, so it is measured on patients. Clinician burnout counts in the next column instead.

Step 3 of 6

Score the operational relief

This column counts capacity freed, staff time returned and delays removed. The saved time has to show up somewhere you can measure it.

Step 4 of 6

Score the money

The money is counted after the cost of running the tool, including the staff who act on what it produces. Leaving that cost out makes this column look better than it is.

Step 5 of 6

Two of six meet the bar on all three

Discharge and transition optimization and dementia care coordination reach Moderate or better on all three. That matters because a project that is strong on two outcomes and weak on the third can launch and still not be renewed.

Step 6 of 6

Ambient documentation does not meet it yet

It scores Emerging on patient outcomes and on money. The first major study across several health systems and vendors found it saved about 16 minutes of documentation time per 8 scheduled patient hours, which the study's senior author called modest. If you pilot it, measure your own numbers before it starts, so you have something to compare against afterward.

Tyler Kent scored each use case against published evidence as of September 2026. The explorer lists the evidence behind every score.

Explore

The map, with the sources

Filter by verdict and select a bubble. Every claim behind a score is listed with its source; the ones without a source say so.

Fig. 1, interactive

Evidence against momentum

Bubble size: deployment readiness

Scored by Tyler Kent in September 2026. Each claim links to its source.

Open the evidence map on its own

Explore

The test, with the evidence

Select a use case for the evidence behind each score, what goes wrong, and how to measure it at your organization.

Fig. 5, interactive

Each use case scored on three outcomes

Scored by Tyler Kent in September 2026. Each claim links to its source.

Open the three-outcome test on its own

AI Vendor Evaluation

Comparing AI vendors?

We score the vendors on your shortlist against the same kind of evidence, testing each one on cases from your own organization, in two weeks, from $7,500. No vendor pays us.

Prefer to skip the call? Get a written proposal

Or see how the AI Vendor Evaluation works.